U.S. OKs New Colon-Cancer Drug

Listen Now:

Real Media|Windows Media Explain these links

Morning Edition, February 27, 2004 · The Food and Drug Administration approves a new drug for colon cancer -- the second-biggest cancer killer. Called Avastin, the new drug blocks tumors' blood supply. Earlier in February, the FDA approved Erbitux, which shrinks colon tumors by blocking a protein they need to grow. Each drug is the first of its kind. NPR's Richard Knox reports.

E-mail|
Share|
Comments |

E-mail this Page

Recipient's e-mail address:	» Up to twelve addresses, separated by commas.
Your e-mail address:
Your name:
Personal message (optional, 600 characters max):
Your NPR member station:
Are you a member of your local NPR station?	Yes No
Would you like to receive information from your local NPR member station? (see NPR's privacy policy)	Yes No
Please send me updates from NPR.	Yes No

(Information collected by NPR will be used solely for internal NPR or NPR member station purposes and only if you selected 'yes' above. See NPR's privacy policy for more information.)

Comments

Discussions for this story are now closed. Please see the Community FAQ for more information.

Learn more: Podcasts | RSS

Feeds

PodcastRSS

Health & Science
Subscribe to Health & Science podcast via:
Or use this URL:
close [x]
Morning Edition–

U.S. OKs New Colon-Cancer Drug

E-mail this Page

Comments

Feeds

More Health & Science

Search 'Morning Edition'

Browse Topics

Services

Programs